These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 3771124)

  • 1. S.E.M. study of urease-induced crystalluria in the presence of hydroxamic derivatives.
    Ben Amar M; L'Espérance G; Tawashi R
    Int Urol Nephrol; 1986; 18(3):227-33. PubMed ID: 3771124
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ureaplasma urealyticum-induced crystallization of magnesium ammonium phosphate and calcium phosphates in synthetic urine.
    Grenabo L; Brorson JE; Hedelin H; Pettersson S
    J Urol; 1984 Oct; 132(4):795-9. PubMed ID: 6381769
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Physicochemical changes of urine environment on propionhydroxamic acid therapy.
    Bruno M; Marangella M; Tricerri A; Martini C; Linari F
    Contrib Nephrol; 1987; 58():207-11. PubMed ID: 3691128
    [No Abstract]   [Full Text] [Related]  

  • 4. Propionhydroxamic acid in the management of struvite urinary stones.
    Puppo P; Germinale F; Bottino P; Ricciotti G; Giuliani L
    Contrib Nephrol; 1987; 58():201-6. PubMed ID: 3691127
    [No Abstract]   [Full Text] [Related]  

  • 5. In vitro inhibition of struvite crystal growth by acetohydroxamic acid.
    Downey JA; Nickel JC; Clapham L; McLean RJ
    Br J Urol; 1992 Oct; 70(4):355-9. PubMed ID: 1450840
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mineralogical studies of urine: the relationship of apatite, brushite and struvite to urinary pH.
    ELLIOT JS; QUAIDE WL; SHARP RF; LEWIS L
    J Urol; 1958 Oct; 80(4):269-71. PubMed ID: 13576608
    [No Abstract]   [Full Text] [Related]  

  • 7. The effect of oral acetohydroxamic acid on urinary saturation in stone-forming spinal cord patients.
    Burr RG; Nuseibeh I
    Br J Urol; 1983 Apr; 55(2):162-5. PubMed ID: 6839086
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Causes of phosphate stone formation and the importance of metaphylaxis by urinary acidification: a review.
    Hesse A; Heimbach D
    World J Urol; 1999 Oct; 17(5):308-15. PubMed ID: 10552150
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Computerized in vivo research from the growth of urease-producing bacteria in the presence of antibiotics combined with propionhydroxamic acid.
    Rizzo M; Nicoletti P; Bartoletti R; Luciani E
    Contrib Nephrol; 1987; 58():219-21. PubMed ID: 3319403
    [No Abstract]   [Full Text] [Related]  

  • 10. [Urinary calculi and infection].
    Trinchieri A
    Urologia; 2014; 81(2):93-8. PubMed ID: 24874306
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Applicability of biosuppressin as an urease-inhibitor.
    Jávor A; Frang D; Nagy Z
    Int Urol Nephrol; 1984; 16(3):191-4. PubMed ID: 6480281
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Treatment of infectious renal lithiasis with acetohydroxamic acid].
    Ruiz Marcellán FJ; Bernshtam Ballester J; Pinto Mateos B
    Arch Esp Urol; 1983; 36(5):354-62. PubMed ID: 6660940
    [No Abstract]   [Full Text] [Related]  

  • 13. A simple technique for studying struvite crystal growth in vitro.
    McLean RJ; Downey J; Clapham L; Nickel JC
    Urol Res; 1990; 18(1):39-43. PubMed ID: 2180168
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Acetohydroxamate in struvite stones: in vivo study.
    Aroldi A; Graziani G; Castelnovo C; Colussi G; Surian M; Mandressi A; Mascheroni E; Pazardjiklian I; Pagano A; Ponticelli C
    Proc Eur Dial Transplant Assoc; 1983; 20():469-72. PubMed ID: 6657671
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Low-dose propionhydroxamic acid therapy in infection-induced stones.
    Colussi G; Surian M; De Ferrari ME; Rombolà G; Rolando P; Minetti L
    Contrib Nephrol; 1987; 58():230-2. PubMed ID: 3691134
    [No Abstract]   [Full Text] [Related]  

  • 16. How variations in the composition of urine influence urease-induced crystallization.
    Hugosson J; Grenabo L; Hedelin H; Pettersson S; Tarfusser I
    Urol Res; 1990; 18(6):413-7. PubMed ID: 2100418
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Struvite crystal formation by Corynebacterium group D2 in human urine and its prevention by acetohydroxamic acid.
    Soriano F; Ponte C; Santamaría M; Fernández-Roblas R
    Eur Urol; 1987; 13(4):271-3. PubMed ID: 3653169
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Food intake and struvite crystalluria in ferrets.
    Palmore WP; Bartos KD
    Vet Res Commun; 1987; 11(6):519-26. PubMed ID: 3451569
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prevention of infected urinary stones in rats by urease inhibitor: a new hydroxamic acid derivative.
    Takeuchi H; Kobashi K; Yoshida O
    Invest Urol; 1980 Sep; 18(2):102-5. PubMed ID: 6997228
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition of crystallization caused by Proteus mirabilis during the development of infectious urolithiasis by various phenolic substances.
    Torzewska A; Rozalski A
    Microbiol Res; 2014; 169(7-8):579-84. PubMed ID: 24239192
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.